SCHEMBL13655841

SCHEMBL13655841

N=Nc1cc(Cl)ccc1F

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.35
TSHR P16473 6/20 0.33
CYP3A4 P08684 4/20 0.33
TDP1 Q9NUW8 3/20 0.33
CASP3 P42574 1/20 0.33
SENP7 Q9BQF6 1/20 0.33
SENP6 Q9GZR1 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MAPK1 P28482 1/20 0.33
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33
HTR2B P41595 1/20 0.33
ALDH1A1 P00352 3/20 0.32
ALOX15 P16050 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
CYP2A6 P11509 2/20 0.32
LMNA P02545 1/20 0.32
HSD17B10 Q99714 2/20 0.31
AHR P35869 1/20 0.31
TAAR1 Q96RJ0 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12440864 0.84 HTR2A (0.36) TP53TSHRCYP3A4TDP1MAPK1
SCHEMBL14273762 0.78 CA3 (0.42) TDP1L3MBTL1MAPK1ALDH1A1SMN1; SMN2
SCHEMBL11709281 0.78 TP53 (0.48) TP53TSHRCYP3A4TDP1CASP3
SCHEMBL13543520 0.76 TP53 (0.35) TP53TSHRCYP3A4TDP1CASP3
SCHEMBL6945799 0.74 CASP3 (0.53) TSHRCYP3A4TDP1CASP3SENP7
SCHEMBL12440436 0.73 TP53 (0.48) TP53TSHRCYP3A4TDP1MAPK1
SCHEMBL1021879 0.71 HTR2B (0.34) TP53CYP3A4TDP1CASP3SENP7
SCHEMBL1569005 0.71 TDP1 (0.39) TP53CYP3A4TDP1CASP3SENP7
SCHEMBL12166517 0.70 HTR3E (0.54) CYP3A4L3MBTL1MAPK1ALDH1A1LMNA
SCHEMBL11984875 0.70 ALDH1A1 (0.46) TP53TSHRCYP3A4MAPK1HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1515724-B1 MITOTIC KINESIN INHIBITORS MERCK & CO INC (US) 2009-10-21 EP disclosed
US-7348440-B2 Kinesin spindle protein (KSP) inhibitors, e.g., 4-(2,5-Difluorophenyl)-N-[(3S,4S)-3-fluoropiperidin-4-yl]-2-hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1N-pyrrole-1-carboxamide, and a carrier; antiproliferative and -carcinogenic agents; side effects reduction; used with an estrogen receptor modulator MERCK & CO., INC. (US) 2008-03-25 US disclosed